Christine Wu Nordahl is professor of psychiatry and behavioral sciences at the University of California, Davis MIND Institute.
Christine Wu Nordahl
Assistant professor
University of California, Davis
From this contributor
Early brain enlargement augurs distinct form of autism
A minority of boys with autism have brains that are unusually large relative to their bodies — a trait tied to regression and intellectual disability.
Early brain enlargement augurs distinct form of autism
Questions for Nordahl, Mello: Scans for children with autism
Techniques used in behavioral interventions could help scientists scan the brains of children who have both autism and intellectual disability.
Questions for Nordahl, Mello: Scans for children with autism
Charting typical brain development
How can we characterize what is atypical when we don’t fully understand what typical brain development looks like, particularly under the age of 5? Christine Wu Nordahl explains the importance of scanning the brains of typically developing children.
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.